Company Description

Autonomix Medical, Inc., a development stage medical device company, focuses on advancing technologies for sensing and treating disorders of nervous system.

The company’s technology platform includes a catheter-based system incorporating microchip-enabled sensing architecture designed to detect low-amplitude neural signals from within the vascular system.

It develops technology for patients with pancreatic cancer and addresses indications for chronic pain management, hypertension, cardiovascular, and other nerve-related disorders.

Autonomix Medical, Inc. was incorporated in 2014 and is headquartered in The Woodlands, Texas.

Autonomix Medical, Inc.

Country	United States
Founded	2014
Industry	Medical Devices
Sector	Healthcare
Employees	11
CEO	Bradley Hauser

Contact Details

Address: 21 Waterway Avenue, Suite 300 The Woodlands, Texas 77380 United States
Phone	713 588 6150
Website	autonomix.com

Stock Details

Ticker Symbol	AMIX
Exchange	NASDAQ
Fiscal Year	April - March
Reporting Currency	USD
CIK Code	1617867
CUSIP Number	05330T304
ISIN Number	US05330T3041
Employer ID	47-1607810
SIC Code	3841

Key Executives

Name	Position
Jennifer Cook	Chief Business Officer

Latest SEC Filings

Date	Type	Title
Sep 16, 2026	424B3	Prospectus
Sep 16, 2026	8-K	Current Report
Sep 15, 2026	EFFECT	Notice of Effectiveness
Sep 14, 2026	DEFA14A	Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Sep 14, 2026	DEF 14A	Other definitive proxy statements
Sep 11, 2026	424B5	Filing
Sep 4, 2026	PRE 14A	Other preliminary proxy statements
Sep 4, 2026	S-3	Registration statement under Securities Act of 1933
Aug 26, 2026	8-K	Current Report
Aug 13, 2026	10-Q	Quarterly Report

View All SEC Filings